RESULTS: There have been no prospective trials of PM or PO for the reduction of breast cancer or ovarian cancer incidence or mortality. Most of the available retrospective studies are composed of ...
HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo ...
"Our findings provide a health economics angle on how we can optimize pelvic organ prolapse surgery by addressing coexisting hidden stress incontinence in women with prolapse." — Tsung Mou, MD Many ...
The prevalence of BRCA1 or BRCA 2 mutations is estimated at about 0.2%-0.33% of the population, but these mutations account for 5%-10% of breast cancers and 10%-15% of ovarian cancers among white ...
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- In a dramatic shift of focus in the fight against ovarian cancer, Ovarian Cancer Research Alliance (OCRA), the world's leading ovarian cancer organization, today ...
Once-daily venous thromboembolism (VTE) prophylaxis with 10 mg of rivaroxaban for either 7 or 28 days after bariatric surgery was found to be effective and safe. Venous thromboembolism (VTE) is known ...
Based on long-term studies, many by oral surgeons, approximately 12% of third molars have associated pathology such as cysts (1.7%), resorption on the distal of second molars (4.8%), and periodontal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback